Item 8.01 Other Events.
The Company has updated its clinical development milestones.
The Company is in the process of completing the requirements to answer
regulatory questions and begin the re-submission process in the US. In addition,
the Company is submitting appropriate filing in
The Company will provide further updates to its clinical development schedule as it becomes clearer.
2
© Edgar Online, source